Healx is a startup company focused on predictive drug repurposing and personalised medicine for rare diseases.
|Address:||Charter house, 66-68 Hills Road, Cambridge|
|Membership type:||Corporate 21-50 (£500+VAT pa)|
Healx technology combines genomic data analysis with machine learning and drug development expertise to predict new uses for existing drugs.
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced the appointment of Kate Hilyard PhD as Chief Operating Officer (COO).
3 October 2018Read in full
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, has announced a $10 million Series A funding round, led by Balderton Capital, Europe’s leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.
26 July 2018Read in full